Amyloid‐β peptide (Aβ) oligomers, characteristic symptom of Alzheimer's disease (AD), have
been identified as the most neurotoxic species and significant contributors to …

A major hallmark of Alzheimer's disease is the misfolding and aggregation of the amyloid-β
peptide (Aβ). While early research pointed towards large fibrillar-and plaque-like aggregates …

Alzheimer's disease is a devastating cureless neurodegenerative disorder affecting> 35
million people worldwide. The disease is caused by toxic oligomers and aggregates of …

Amyloid β-protein (Aβ) oligomers are emerging as potent neurotoxic species in Alzheimer's
disease pathogenesis. Detailed characterization of oligomer structure and dynamics is …

The amyloid-β peptide (Aβ) can generate cytotoxic oligomers, and their accumulation is
thought to underlie the neuropathologic changes found in Alzheimer's disease. Known …

Aggregation of amyloid β-peptide (Aβ) is implicated in the pathology of Alzheimer's disease
(AD), with the soluble, Aβ oligomeric species thought to be the critical pathological species …

A key challenge in studying the biological and biophysical properties of amyloid-forming
peptides is that they assemble to form heterogeneous mixtures of soluble oligomers and …

The prevailing hypothesis stipulates that the preamyloid oligomers of Aβ are the main
culprits associated with the onset and progression of Alzheimer's disease (AD), which has …

Small oligomers formed during the aggregation of certain peptides and proteins are highly
cytotoxic in numerous neurodegenerative disorders. Because of their transient nature and …

Alzheimer's disease (AD), an age related neurodegenerative disorder, threatens to become
a major health-economic problem. Assembly of 40-or 42-residue amyloid β-peptides (Aβ) …